Yuki Tsuji

von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C

Hiroaki Takaya, Hideto Kawaratani, Yuki Tsuji et al. · United European Gastroenterology Journal · 2018 · 48 citations · Full text

Medicine, Pathology, Carcinogenesis +16

Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice

Satoshi Iwai, Kosuke Kaji, Norihisa Nishimura et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2023 · 46 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients

Kosuke Kaji, Soichiro Saikawa, Hiroaki Takaya et al. · Antibiotics · 2020 · 42 citations · Full text

Life Sciences, Immunology, Pharmacology +17

VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma

Hiroaki Takaya, Tadashi Namisaki, Mitsuteru Kitade et al. · BMC Gastroenterology · 2019 · 38 citations · Full text

Medicine, Oncology, Pathology +17

Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis

Yukihisa Fujinaga, Hideto Kawaratani, Daisuke Kaya et al. · International Journal of Molecular Sciences · 2020 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16